title: Rapid testing for respiratory syncytial virus in a paediatric emergency department: benefits for infection control and bed management.
abstract: Respiratory syncytial virus (RSV) is responsible for annual winter outbreaks of respiratory tract infection among children in temperate climates, placing severe pressure on hospital beds. Cohorting of affected infants has been demonstrated to be an effective strategy in reducing nosocomial transmission of RSV, and may keep cubicles free for other patients who require them. Testing of symptomatic children for RSV is standard practice, but unfortunately traditional laboratory testing is not rapid enough to aid decision-making processes. Rapid point-of-care testing (POCT) in the emergency department has been suggested as an alternative. We performed a prospective study to quantify the amount of cubicle time saved by using POCT results to allow a targeted cohorting strategy. Over the four-month study period, the POCT allowed 183 children to be admitted directly to a designated cohort area, thus saving 568.5 cubicle-days for other patients. This is equivalent to five cubicles being left free for each day of the study period. This is the first time the benefits of using POCT have been quantified in this way. POCT for RSV is a safe, cost-effective and efficient way to improve bed management.
authors.affiliation: Microbiology Department, Royal Infirmary of Edinburgh, Edinburgh, UK. jonathan.mills@luht.scot.nhs.uk
authors.forename: J M
authors.initials: JM
authors.lastname: Mills
authors.forename: J
authors.initials: J
authors.lastname: Harper
authors.forename: D
authors.initials: D
authors.lastname: Broomfield
authors.forename: K E
authors.initials: KE
authors.lastname: Templeton
mesh_terms: D001513:Beds / Q000191:economics / Q000706:statistics & numerical data*; D002675:Child, Preschool; D003362:Cost-Benefit Analysis; D003428:Cross Infection / Q000453:epidemiology / Q000517:prevention & control; D004636:Emergency Service, Hospital / Q000639:trends*; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D017053:Infection Control / Q000191:economics / Q000379:methods; D008297:Male; D010372:Pediatrics / Q000379:methods*; D019095:Point-of-Care Systems; D016133:Polymerase Chain Reaction / Q000379:methods; D018357:Respiratory Syncytial Virus Infections / Q000175:diagnosis* / Q000191:economics / Q000453:epidemiology / Q000517:prevention & control / Q000821:virology; D018113:Respiratory Syncytial Virus, Human / Q000235:genetics / Q000302:isolation & purification*; D013997:Time Factors